Subgen AI AB (publ) (OM: SUBGEN)
Health Care · Biotechnology · SE
Skr0.04
-18.08% today · -100.0% 1Y
Subgen AI AB (publ) (OM: SUBGEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.83M and employs 251 people.
Over the last twelve months the share price has lost 100.0%, trading between 0.03 and 19.60.
Tweenvest scores Subgen AI AB (publ) across four factors: quality 59/100. Its strongest factor is quality.
SUBGEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.83M
- Revenue (TTM)
- $22.12M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Skr19.60
- 52-week low
- Skr0.03
- Avg volume (3M)
- —
- Shares outstanding
- 1.98B
- Employees
- 251
- Next earnings
- —
About Subgen AI AB (publ)
Subgen AI AB develops artificial intelligence-based models and applications to control data for government and businesses. The company engages in the provision of information society services aimed at delivering financial and related knowledge tools to facilitate third-party access to financial literacy and instruments that enable them to interpret such information through e-learning; the acquisition, ownership, management and administration of securities; and the acquisition, ownership, marketing, leasing and operation of rural or urban properties. It also provides financial intermediation services; computer programming activities, structure and content design, writes computer code for systems, computer software, databases and web pages; and customizes computer programs, including configuration and modification of legacy programs. In addition, the company offers marketing and after-sales services of diagnostic imaging machinery and human resources services, as well as development of state-of-the-art artificial intelligence (Al) systems. Further, it provides Serenity Star, AI4D core, and Substrate Cloud. The company is based in London, United Kingdom. Subgen AI AB operates as a subsidiary of Substrate Artificial Inteligence, S.A.
- ISIN
- SE0026820854
- Listed since
- Dec 10, 2025
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.